A Stage 4 cancer survivor is grateful for a 'lifesaving' clinical trial, but experts are wary over potential federal funding ...

New research shows 92% of cancer patients stayed cancer-free for two years after immune-based therapy, potentially avoiding ...

We are navigating political interference, institutional instability, and growing uncertainty across the cancer research ...

The AACR meeting was full of promising data on the vaccine against cervical cancer, a lung cancer drug and the next ...

Scientists have developed a new, ready-made way to fight acute myeloid leukemia and other blood cancers that looks promising.

AACR president received a standing ovation in rousing call to action for the cancer research community's response to funding ...

More and better kinds of screening as well as new, more targeted treatments are making breast cancer less deadly.

Cancer survivors who reported feeling cancer-related fatigue or depression reduced their recreational activities nearly ...

According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...

This innovative approach challenges the standard treatment path for many cancer patients, which typically includes surgery followed by chemotherapy and radiation. For patients facing difficult ...

Patients with advanced solid tumors experienced significantly improved survival outcomes when receiving a tailored therapy ...